PMI Invested over $12.5 Billion in Smoke-free Technology

PMI by 2FIRSTS.ai
Apr.18.2024
PMI Invested over $12.5 Billion in Smoke-free Technology
Smoking's major health impacts widely known, WHO data shows over billion smokers globally, push for smoke-free alternatives intensifies.

According to a report from El País on April 16th, it is widely known that smoking has significant impacts on health. Therefore, the best choice is to never start smoking or to quit as soon as possible. However, according to data from the World Health Organization (WHO), there are still over a billion smokers worldwide, and this number is not expected to significantly decrease in the near to medium term.

 

Around the world, various methods and strategies have been implemented to help people quit smoking and encourage them to break this habit. These strategies and policies primarily focus on prevention and cessation, aiming to prevent people from starting smoking, especially young individuals, or helping current smokers kick the habit.

 

In recent years, scientists have developed a smokeless alternative through technology, indicating that it is a better choice than continuing to smoke. These alternatives do not involve combustion, are smokeless, and generally contain the addictive substance nicotine. Evidence shows that compared to traditional cigarettes, this method significantly reduces health risks. When smoking cigarettes, tobacco is burned at high temperatures, producing smoke that contains over 6000 chemical substances, including around a hundred that are proven or potentially harmful. Therefore, eliminating the combustion process is the main goal in developing smoking alternatives.

 

Such alternatives include e-cigarettes (commonly referred to as e-liquid or vape), which do not contain tobacco and only have nicotine solution, as well as heat-not-burn tobacco devices that, although they contain tobacco, only heat it up instead of burning it, resulting in significantly reduced harmful chemicals released compared to burning tobacco.

 

In addition, Philip Morris International (PMI) has been dedicated to seeking non-combustible alternative products. They continue to invest in technology and collaborate with partners to drive the global goal of achieving a smoke-free future. Since 2008, PMI has invested approximately $12.5 billion in research and development of new technologies, establishing a scientific evidence base, product manufacturing, marketing, and continued innovation.

 

Therefore, it is possible to help eliminate the impact of smoking on public health. However, this is not something that can be achieved overnight or by one party alone, but it requires cooperation from other relevant parties such as public authorities, the medical community, and the scientific community. Only in this way will there be real changes that have an impact on public health. At the same time, accurate information based on scientific evidence must be provided to adult smokers so that they can make informed decisions.

 

The PMI company stated that "with the appropriate regulatory environment, societal dialogue, and public support, many countries are expected to achieve smoke-free status within 10 to 15 years".

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

West Virginia Bill Would Direct USD 2.9 Million of Juul Settlement to Youth Tobacco and Vaping Prevention
West Virginia Bill Would Direct USD 2.9 Million of Juul Settlement to Youth Tobacco and Vaping Prevention
A bill completed during West Virginia’s 2026 regular legislative session would make a one-time allocation of USD 2.9 million from the state’s USD 7.9 million settlement with Juul to youth tobacco prevention and cessation programs.
Mar.19 by 2FIRSTS.ai
Patent Reveals China Tobacco Hubei Industrial Testing Animal Model for Heated Tobacco Safety Evaluation
Patent Reveals China Tobacco Hubei Industrial Testing Animal Model for Heated Tobacco Safety Evaluation
China Tobacco Hubei Industrial Co., Ltd. has published a patent describing a laboratory method to evaluate the reproductive and developmental safety of heated tobacco products using non-human animal exposure models. The approach introduces a structured toxicological testing framework that could support safety verification, quality control, and regulatory evidence generation for heated tobacco products.
Mar.09
STG UK refreshes XQS nicotine pouch packaging: new flavour indicators, hitting retail from March
STG UK refreshes XQS nicotine pouch packaging: new flavour indicators, hitting retail from March
Scandinavian Tobacco Group UK (STG UK) has announced a rebrand across its XQS nicotine pouch range. The updated packaging will be visible at retail from March, with the recommended retail price remaining £5.50. The new packs feature a bolder logo and glossy textures, retain nicotine strength indicators, and add a side flavour profile indicator to show the flavour type.
Feb.28 by 2FIRSTS.ai
UKVIA Says VApril 2026 Will Highlight Consumer Impact of Tobacco and Vapes Bill
UKVIA Says VApril 2026 Will Highlight Consumer Impact of Tobacco and Vapes Bill
The UK Vaping Industry Association said it will launch the ninth annual VApril campaign next month. The association described VApril as the world’s largest vape awareness initiative and said it has for almost a decade supported adult smokers looking to quit through vaping by providing evidence-based information, expert insights and practical guidance
Mar.24 by 2FIRSTS.ai
Philip Morris Korea to Launch IQOS Iluma i One “Electric Purple” Color, Expanding Into Major Convenience Store Channels From May
Philip Morris Korea to Launch IQOS Iluma i One “Electric Purple” Color, Expanding Into Major Convenience Store Channels From May
Philip Morris Korea said on March 31 that it will begin selling the new “Electric Purple” color for the heated tobacco device IQOS Iluma i One at major convenience stores nationwide in South Korea starting May 2. The color will first be introduced on April 10 at the official IQOS online store and nine IQOS directly operated stores nationwide. To mark the expansion of its sales channels, the company will run promotions at major convenience stores through May 20.
Mar.31
Rethinking Nicotine Harm Reduction: A Neuroscientist’s Perspective on Scientific Gaps and Future Directions — By Dr. Xin-an Liu
Rethinking Nicotine Harm Reduction: A Neuroscientist’s Perspective on Scientific Gaps and Future Directions — By Dr. Xin-an Liu
After France’s ANSES report on nicotine products and harm reduction, Dr. Xin-an Liu wrote to 2Firsts reassessing the field’s foundations. She argues the debate reveals gaps in evidence on long-term behavioral substitution, addiction pathways and neurobiological impacts, and calls for longitudinal research, integrated behavioral science and neuroimaging, clearer risk assessment and stronger transparency to ensure policy and next-generation product development rest on solid evidence.
Industry Insight
Feb.24